BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20851107)

  • 1. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production.
    He X; Andersson G; Lindgren U; Li Y
    Biochem Biophys Res Commun; 2010 Oct; 401(3):356-62. PubMed ID: 20851107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells.
    Kharkwal G; Chandra V; Fatima I; Dwivedi A
    J Mol Endocrinol; 2012 Jun; 48(3):261-70. PubMed ID: 22493142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
    Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
    Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation.
    Moon HJ; Ko WK; Han SW; Kim DS; Hwang YS; Park HK; Kwon IK
    Biochem Biophys Res Commun; 2012 Feb; 418(2):247-53. PubMed ID: 22252298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.
    Yip KH; Zheng MH; Steer JH; Giardina TM; Han R; Lo SZ; Bakker AJ; Cassady AI; Joyce DA; Xu J
    J Bone Miner Res; 2005 Aug; 20(8):1462-71. PubMed ID: 16007343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safflower seed extract inhibits osteoclast differentiation by suppression of the p38 mitogen-activated protein kinase and IκB kinase activity.
    Moon HJ; Kim EK; Nam YS; Kim JH; Ko WK; Lee JM; Lee CH; Jang JB; Lee KS; Kwon IK
    Phytother Res; 2012 Nov; 26(11):1648-55. PubMed ID: 22389167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc.
    Qu B; Gong K; Yang H; Li Y; Jiang T; Zeng Z; Cao Z; Pan X
    Mol Cell Endocrinol; 2018 Oct; 474():97-104. PubMed ID: 29486220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
    Kondo H; Takeuchi S; Togari A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biselyngbyaside, isolated from marine cyanobacteria, inhibits osteoclastogenesis and induces apoptosis in mature osteoclasts.
    Yonezawa T; Mase N; Sasaki H; Teruya T; Hasegawa S; Cha BY; Yagasaki K; Suenaga K; Nagai K; Woo JT
    J Cell Biochem; 2012 Feb; 113(2):440-8. PubMed ID: 21678460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.
    Sasaki H; Yamamoto H; Tominaga K; Masuda K; Kawai T; Teshima-Kondo S; Matsuno K; Yabe-Nishimura C; Rokutan K
    Free Radic Biol Med; 2009 Jul; 47(2):189-99. PubMed ID: 19409483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
    Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
    J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism.
    Gambari L; Lisignoli G; Cattini L; Manferdini C; Facchini A; Grassi F
    Pharmacol Res; 2014 Sep; 87():99-112. PubMed ID: 24998607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.